You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRx-401

Showing 1 - 25 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolemia Trial in Sydney, Morayfield, Melbourne (VXX-401, Placebo)

Recruiting
  • Hypercholesterolemia
  • Sydney, New South Wales, Australia
  • +2 more
Mar 15, 2023

Pulmonary Hypertension, Interstitial Lung Disease Trial (LIQ861)

Not yet recruiting
  • Pulmonary Hypertension
  • Interstitial Lung Disease
  • LIQ861
  • (no location specified)
Nov 10, 2023

Rett Syndrome Trial in Aurora, Boston, Houston (NGN-401)

Recruiting
  • Rett Syndrome
  • NGN-401
  • Aurora, Colorado
  • +2 more
Jun 12, 2023

Multiple Sclerosis Trial in Stockholm (Temelimab 18 mg/kg, Temelimab 36mg/kg, Temelimab 54 mg/kg)

Terminated
  • Multiple Sclerosis
  • Temelimab 18 mg/kg
  • +2 more
  • Stockholm, Sweden
    Center for Neurology, Academic Specialist Center
Jul 4, 2022

Hearing Loss Trial in Melbourne (SENS-401 (R-Azasetron Besylate))

Recruiting
  • Hearing Loss
  • SENS-401 (R-Azasetron Besylate)
  • Melbourne, Australia
    Royal Victorian Eye and Ear Hospital
Jul 8, 2022

Diabetic Macular Edema Trial (K8)

Not yet recruiting
  • Diabetic Macular Edema
  • (no location specified)
Jan 27, 2023

Ulcerative Colitis Trial in Worldwide (BBT-401-1S, Placebo)

Completed
  • Ulcerative Colitis
  • Little Rock, Arkansas
  • +31 more
Oct 18, 2022

Health Related Social Needs (HRSN) Trial in Chicago (Community Rx-Caregiver Resources)

Enrolling by invitation
  • Health Related Social Needs (HRSN)
  • Community Rx-Caregiver Resources
  • Chicago, Illinois
    University of Chicago
Sep 27, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Tucson, Arizona
  • +23 more
Dec 14, 2021

Narcolepsy Trial in United States (JZP-258)

Recruiting
  • Narcolepsy
  • Alabaster, Alabama
  • +27 more
Jul 22, 2022

Recurrent Vulvovaginal Candidiasis Trial in Cairo (Blue Light Emitting Diode Therapy, Azole Antifungal)

Enrolling by invitation
  • Recurrent Vulvovaginal Candidiasis
  • Blue Light Emitting Diode Therapy
  • Azole Antifungal
  • Cairo, Egypt
    Faculty of physical therapy, Cairo University
Apr 1, 2023

Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib, Rituximab, Bendamustine)

Recruiting
  • Follicular Lymphoma (FL)
  • +2 more
  • Tucson, Arizona
  • +134 more
Jul 27, 2022

Hearing Loss Ototoxic Trial (SENS-401 (R-Azasetron Besylate))

Not yet recruiting
  • Hearing Loss Ototoxic
  • SENS-401 (R-Azasetron Besylate)
  • (no location specified)
Nov 16, 2022

Acute Myeloid Leukemia, Stem Cell Transplantation Trial in United States (MT-401)

Recruiting
  • Acute Myeloid Leukemia
  • Stem Cell Transplantation
  • Birmingham, Alabama
  • +15 more
Aug 22, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Multiple Myeloma Trial in Duarte, Boston, Portland (SL-401/ Pomalidomide/ Dexamethasone)

Terminated
  • Multiple Myeloma
  • SL-401/ Pomalidomide/ Dexamethasone
  • Duarte, California
  • +2 more
Jan 13, 2022

Atopic Dermatitis Trial in United States (FB-401)

Terminated
  • Atopic Dermatitis
  • FB-401
  • Fremont, California
  • +7 more
Oct 22, 2021

Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib (ME-401))

Recruiting
  • Follicular Lymphoma (FL)
  • +2 more
  • Zandelisib (ME-401)
  • Tucson, Arizona
  • +115 more
Mar 8, 2022

Severe Sudden Sensorineural Hearing Loss Trial in Paris (SENS-401, Placebo Oral Tablet)

Completed
  • Severe Sudden Sensorineural Hearing Loss
  • Paris, France
    Hôpital Lariboisière
Jan 28, 2022

Non-GCB/ABC DLBCL, With and Without MyD88 and/or CD79B Mutations Trial in Cleveland, Toledo (Mivavotinib)

Recruiting
  • Non-GCB/ABC Diffuse Large B-Cell Lymphoma
  • With and Without MyD88 and/or CD79B Mutations
  • Evanston, Illinois
  • +6 more
Dec 12, 2022

Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Nov 30, 2021

Ulcerative Colitis Trial in United States (BBT-401-1S first and then Placebo, Placebo first and then BBT-401-1S)

Terminated
Has Results
  • Ulcerative Colitis
  • BBT-401-1S first and then Placebo
  • Placebo first and then BBT-401-1S
  • Sacramento, California
  • +10 more
Feb 23, 2022

Atopic Dermatitis Trial in United States (FB-401, Placebo)

Completed
  • Atopic Dermatitis
  • FB-401
  • Placebo
  • Fountain Valley, California
  • +14 more
Sep 14, 2021

Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma Trial in Japan (ME-401)

Active, not recruiting
  • Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
  • Nagoya, Aichi, Japan
  • +5 more
Dec 10, 2021

Indolent B-cell Non-Hodgkin's Lymphoma Trial in Japan (ME-401)

Active, not recruiting
  • Indolent B-cell Non-Hodgkin's Lymphoma
  • Anjo, Aichi, Japan
  • +29 more
Dec 10, 2021